UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Charter)
(State or Other Jurisdiction | (Commission File | (IRS Employer |
of Incorporation) | Number) | Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events
As previously announced on December 23, 2019, Magellan Medicaid Administration, Inc. (“MMA”), a subsidiary of Magellan Health, Inc. (the “Company”), and the California Department of Health Services (“DHCS”) entered into a contract for the provision of pharmacy benefit administration services statewide following the issuance of a decision that upheld the contract award to MMA over a protest filed by an unsuccessful bidder. On February 17, 2020, the Company was notified that the unsuccessful bidder filed an action against DHCS in California state court seeking to overturn the protest decision and contract award (and identifying MMA as a “real party in interest”). The state court action is based on similar arguments that were previously unsuccessful at the administrative level. MMA will vigorously oppose the action in conjunction with DHCS’s defense of the unsuccessful bidder’s claims in the state court action. However, there can be no assurance that the unsuccessful bidder will not prevail in the state court action or that the state court action will not cause a delay in implementation of the contract.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MAGELLAN HEALTH, INC.
Date: February 20, 2020 | By: | /s/ Jonathan N. Rubin | |
Name: Jonathan N. Rubin | |||
Title: Chief Financial Officer | |||
3